Superworth

Decoy Therapeutics EPS DCOY

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
n/m
a quarter missing
Latest quarter, Q2 FY26
−$4.46
Fiscal year 2024
−$1335.36

Decoy Therapeutics' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was −$4.46.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2024−$1335.36n/a
FY2023−$6532.20n/a
FY2022−$21225.60n/a
FY2021−$10958.40n/a
FY2020−$19800.00n/a
FY2019−$76680.00n/a
FY2018−$970200.00n/a
FY2017−$1800000.00n/a
FY2016−$2205000.00n/a
FY2015−$1890000.00n/a
FY2014n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$4.46n/an/a
Q1 FY26−$4.18n/an/a
Q3 FY25−$21.72n/a−$526.60
Q2 FY25−$81.21n/a−$641.44
Q1 FY25−$240.07n/a−$986.83
Q4 FY24−$183.60n/a−$1335.36
Q3 FY24−$136.56n/a−$1473.96
Q2 FY24−$426.60n/a−$2275.20
Q1 FY24−$588.60n/a−$3909.60
Q4 FY23−$322.20n/a−$6532.20
Q3 FY23−$937.80n/a−$10285.20
Q2 FY23−$2061.00n/a−$18577.80

Against its peers

Companies in Drug Manufacturers - General nearest Decoy Therapeutics' size, closest first, today.

CompanyEPS, 12 months
DCOYDecoy Therapeuticsn/m
SBFMSunshine Biopharman/m
JAGXJaguar Health−$6051.75
LABTLakewood-Amedex Biotherapeuticsn/m
NXTSNexentis Technologiesn/m
VBIOValion Bion/m
ARTLArtelo Biosciences−$207.09
LNAILunai Bioworksn/m
GNPXGenprexn/m
GOVXGeoVax Labsn/m
ONCOOnconetix−$199.38
Peer median−$207.09

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Decoy Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.